CRIS Current Research Information System

RAVAIOLI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 26.342
NA - Nord America 24.830
EU - Europa 17.847
AF - Africa 1.460
SA - Sud America 1.421
Continente sconosciuto - Info sul continente non disponibili 1.265
OC - Oceania 57
Totale 73.222
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.228
VN - Vietnam 7.975
SG - Singapore 6.446
CN - Cina 5.700
IT - Italia 4.740
GB - Regno Unito 2.856
DE - Germania 2.261
HK - Hong Kong 2.116
SE - Svezia 1.652
NL - Olanda 1.622
IN - India 1.177
FR - Francia 1.160
BR - Brasile 1.030
BD - Bangladesh 714
RU - Federazione Russa 697
KR - Corea 591
IE - Irlanda 584
UA - Ucraina 546
FI - Finlandia 418
JP - Giappone 398
CI - Costa d'Avorio 388
CA - Canada 317
TG - Togo 303
ZA - Sudafrica 302
CH - Svizzera 237
SC - Seychelles 206
EE - Estonia 189
PH - Filippine 175
BG - Bulgaria 169
AR - Argentina 159
ES - Italia 159
JO - Giordania 145
TH - Thailandia 137
AT - Austria 131
ID - Indonesia 118
MX - Messico 117
TR - Turchia 103
IQ - Iraq 100
NG - Nigeria 97
PL - Polonia 93
BE - Belgio 75
TW - Taiwan 72
EC - Ecuador 69
PK - Pakistan 67
SA - Arabia Saudita 51
UZ - Uzbekistan 48
AU - Australia 47
IR - Iran 45
MA - Marocco 38
RO - Romania 37
CL - Cile 35
CR - Costa Rica 34
EG - Egitto 33
HR - Croazia 33
LT - Lituania 33
CO - Colombia 32
JM - Giamaica 32
GR - Grecia 26
MY - Malesia 25
PE - Perù 23
VE - Venezuela 22
PY - Paraguay 21
HN - Honduras 20
UY - Uruguay 20
AE - Emirati Arabi Uniti 19
KE - Kenya 18
PT - Portogallo 15
MK - Macedonia 14
NP - Nepal 14
TN - Tunisia 14
ET - Etiopia 13
PR - Porto Rico 13
HU - Ungheria 12
RS - Serbia 12
AL - Albania 11
CZ - Repubblica Ceca 11
DZ - Algeria 11
NI - Nicaragua 11
AZ - Azerbaigian 10
LB - Libano 10
PS - Palestinian Territory 9
SV - El Salvador 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
IL - Israele 8
KZ - Kazakistan 8
LV - Lettonia 8
GT - Guatemala 7
KH - Cambogia 7
NZ - Nuova Zelanda 7
TT - Trinidad e Tobago 7
EU - Europa 6
GP - Guadalupe 6
LK - Sri Lanka 6
LU - Lussemburgo 6
NO - Norvegia 6
OM - Oman 6
PA - Panama 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
Totale 71.842
Salva come PNG Salva come JPEG
Città #
Singapore 4.502
Ashburn 2.766
Southend 2.264
Hong Kong 1.977
Ho Chi Minh City 1.910
Fairfield 1.897
Chandler 1.683
Hanoi 1.653
San Jose 1.447
Hefei 1.141
Santa Clara 974
Dong Ket 912
Woodbridge 907
Bologna 854
Houston 802
Wilmington 794
Seattle 786
Council Bluffs 710
Princeton 690
Kerkrade 651
Beijing 646
Cambridge 643
Boardman 608
Los Angeles 604
Dublin 581
Seoul 512
Frankfurt am Main 502
Dallas 471
Ann Arbor 453
Lauterbourg 393
Abidjan 387
New York 376
Milan 362
Eygelshoven 338
Tokyo 335
Helsinki 331
Lomé 303
Jacksonville 302
Da Nang 280
Haiphong 250
Nanjing 238
Buffalo 237
Westminster 230
Rome 221
Berlin 215
Padova 203
Munich 195
São Paulo 184
Bern 174
Florence 173
Sofia 165
Turin 152
Redondo Beach 147
Jinan 146
Amman 142
Guangzhou 133
Saint Petersburg 123
Shanghai 122
Shenyang 122
San Diego 119
London 107
Chicago 106
Bengaluru 105
Biên Hòa 104
Changsha 102
Phoenix 100
Redmond 97
Johannesburg 93
Des Moines 90
Hải Dương 90
Toronto 89
Amsterdam 86
Medford 86
The Dalles 85
Dearborn 83
Naples 81
Falkenstein 77
Can Tho 76
Montreal 76
Abeokuta 75
Bremen 74
Orem 74
Brooklyn 73
Nanchang 73
Delhi 72
Zhengzhou 72
Vienna 69
Nuremberg 68
San Francisco 68
Atlanta 67
Hebei 67
Thái Nguyên 67
Brussels 66
Hyderabad 66
Quận Bình Thạnh 63
Tianjin 63
Jakarta 61
Hangzhou 60
Jiaxing 60
Düsseldorf 59
Totale 44.588
Salva come PNG Salva come JPEG
Nome #
[Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer] 1.644
Long Term Outcomes of Kidney Transplant: Characteristics of Recipients with 20 or More Years of Graft Survival 888
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 754
The histological assessment of liver fibrosis in grafts from extended criteria donors predicts the outcome after liver transplantation: A retrospective study 656
Utilizzo della perfusione ex-vivo in pazienti con epatocarcinoma candidati al trapianto di fegato per ridurre l’incidenza di recidiva del tumore 613
Hepatobiliary Scintigraphy in the Preoperative Evaluation of Potential Living Liver Donors 505
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 490
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 474
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 379
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 375
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 374
Impact of Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection 370
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 355
TRAPIANTO DI FEGATO CON TROMBOSI PORTALE COMPLETA: ESPERIENZA DI 11 CASI TRATTATI MEDIANTE ANASTOMOSI TRA LA VENA PORTA DEL GRAFT E LA VARICE GASTRICA DEL RICEVENTE 336
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 335
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 333
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 315
A comprehensive analysis on expected years of life lost due to pancreatic cancer 313
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 303
Applicazioni innovative di vescicole extracellulari derivanti da cellule staminali mesenchimali a scopo di ricondizionamento di reni per il trapianto 287
Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial 285
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study 281
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 274
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 271
A new liver transplant priority for patients with hepatocellular carcinoma. 269
Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation 266
Hypothermic Oxygenated Perfusion in Extended Criteria Donor Kidney Transplantation-A Randomized Clinical Trial 257
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. 256
Machine Learning Pipeline for the Automated Prediction of MicrovascularInvasion in HepatocellularCarcinomas 255
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. 255
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 251
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 250
Risk Factors of Acute Rejection: Impact on Graft Outcomes in a Cohort of Kidney Transplant Recipients 248
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 245
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 241
Surgical therapy for hepatolithiasis: a Western experience. 241
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 240
The physical, sedimentary and ecological structure and variability of shelf areas in the Mediterranean Sea 239
Long-term outcomes after hypothermic oxygenated machine perfusion and transplantation of 1,202 donor livers in a real-world setting (HOPE-REAL study) 238
Hypothermic oxygenated perfusion in extended criteria donor liver transplantation-A randomized clinical trial 237
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 235
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts. 234
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. 233
Histological Evidence of Diabetic Kidney Disease Precede Clinical Diagnosis 233
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma 232
A partnership model between high- And low-volume hospitals to improve results in hepatobiliary pancreatic surgery 232
A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18. 230
LncRNAs as novel players in hepatocellular carcinoma recurrence 229
Delaying surgery for patients with a previous SARS-CoV-2 infection 229
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 222
Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature 221
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 221
Complex Liver Transplantation Using Venovenous Bypass With an Atypical Placement of the Portal Vein Cannula 220
Hepatopancreatoduodenectomy for locally advanced perihilar cholangiocarcinoma: A case report and a plea not to underestimate surgical resectability 218
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 218
Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation 217
Automatically extracted machine learning features from preoperative CT to early predict microvascular invasion in HCC: the role of the Zone of Transition (ZOT) 217
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 216
Combined liver–dual kidney transplant: Role in expanded donors 216
Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato 216
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 215
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 214
Coping strategies in intestinal transplantation 214
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 213
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 213
Strategies to improve function of marginal grafts and to recover discharged grafts in standard and complex liver and kidney transplantation 213
“Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy 212
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 212
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 210
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 208
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 208
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 208
Heterotopic auxiliary segment 2–3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases 207
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 207
The Relationship between Timing of Pretransplant Kidney Biopsy, Graft Loss, and Survival in Kidney Transplantation: An Italian Cohort Study 207
Risk factors for IgA nephropathy recurrence and impact on graft survival in a cohort of kidney transplanted patients 206
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 206
Radiomic Analysis of Intrahepatic Cholangiocarcinoma: Non-Invasive Prediction of Pathology Data: A Multicenter Study to Develop a Clinical-Radiomic Model 205
Prediction of Three-Year Outcome of Renal Transplantation from Optimal Donors versus Expanded Criteria Donors. 204
Thorough assessment of portal venous thrombosis in patients with HCC allows adequate selection of candidates for liver transplantation 204
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 203
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 202
Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma 202
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 202
Aumento della xantina ossidoreduttasi sierica dopo trapianto di fegato 201
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 201
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 200
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 197
Induction therapy with Alemtuzumab (Campath) in combined liver-kidney transplantation: University of Bologna experience. 197
Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: Protocol for a single-center randomized controlled trial 197
Efficacy of MELD score in predicting survival after liver retransplantation. 196
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 194
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 193
Assessment of perioperative transfusion requirement for cirrhotic patients undergoing elective hepatectomy 192
Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications 192
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 191
Impact of preoperative infection on outcome after liver transplantation 191
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. 191
Extracellular Vesicles Derived from Mesenchymal Stromal Cells Delivered during Hypothermic Oxygenated Machine Perfusion Repair Ischemic/Reperfusion Damage of Kidneys from Extended Criteria Donors 190
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? 190
Totale 27.795
Salva come PNG Salva come JPEG
Categoria #
all - tutte 200.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 200.549
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.680 0 216 332 464 535 260 137 564 236 383 1.488 1.065
2022/20237.861 707 1.076 376 929 637 658 298 500 1.336 238 659 447
2023/20242.633 224 436 171 255 177 439 118 164 87 204 176 182
2024/202510.930 525 1.350 968 855 1.423 598 704 353 269 912 793 2.180
2025/202631.212 3.270 3.087 2.300 1.925 2.564 2.601 4.163 887 5.357 2.146 1.455 1.457
2026/20271.676 746 930 0 0 0 0 0 0 0 0 0 0
Totale 73.222